Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

British Pharmacological Society

UK company 02877400, incorporated on 29 November 1993.

British Pharmacological Society is a UK company with status Active founded in 1993.

Company number

02877400

Incorporated

29 Nov 1993

Companies House status

Active

Company identity

Founded / incorporated

29 November 1993

Company number 02877400

Verify at Companies House

Legal name

BRITISH PHARMACOLOGICAL SOCIETY

Company type

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)

Region

Unknown

Registered address

42 WHARF ROAD

LONDON

ENGLAND

N1 7GS

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 2

British Pharmacological Society

No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

6 events

30 Sep

2027

Accounts due

Accounts Due

Next accounts due date

26 Nov

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

23 Jun

2026

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzUyNzkzMDk1OWFkaXF6a2N4

Published 23 Jun 2026 19:25

31 Dec

2025

Accounts filed

Accounts

Last accounts made up date

12 Nov

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

29 Nov

1993

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2024

Funded years

2024

Age at first award

30 years

Projects

2024 Collaborative R&D

UK Regulatory Science and Innovation Network in Pharmacogenomics

1 Mar 2024 to 31 Aug 2024

Awarded

£25,000

Total cost £25,000

More than 20 years ago, the Human Genome Project mapped the genes that make us who we are, paving the way for using information about an individual's genes in health care. 'Pharmacogenomics' studies how our genes influence our response to medicines. We know that differences in the genes that respond to medicines mean that a medicine can work well in some,...

Product types

Collaborative R&D